Source: International Congress 2016 – Update on drug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Irina Kontsevaya (London, United Kingdom), Irina Kontsevaya, Vladyslav Nikolayevskyy, Alexander Kovalyov, Olga Ignatyeva, Edita Vasiliauskiene, Girts Skenders, Yanina Balabanova, Francis Drobniewski. Changes in MIRU-VNTR profiles are associated with treatment failures in tuberculosis patients. Eur Respir J 2016; 48: Suppl. 60, 2684

Member's Comments

No comment yet.

Related content which might interest you: M.Tuberculosis drug susceptibility testing results among previously treated patients in Georgia Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Risk factors for tuberculosis relapse in Polish patients Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Molecular epidemiological analysis of cases of pulmonary tuberculosis in patients with multiple admissions to TB hospital Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Characterization of mycobacterium abscessus subtypes in Shanghai: The drug sensitivity, bacterial epidemicity and clinical manifestations Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Active detection of tuberculosis in homeless populations may reduce the incidence of tuberculosis in the general population Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Genotypes of mycobacterium tuberculosis isolates from autopsy material of HIV-positive tuberculosis patients in Russia Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 The change of tuberculosis features through decades in immune-competent patients Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Treatment effectiveness of TB patients from different groups of population in Moscow Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Assessing gender differences among tuberculosis suspects and patients in Guinea-Bissau Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Current status of fluoroquinolone use for treatment of tuberculosis in Korea Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Features of different M.tuberculosis strains that were isolated from MDR-TB patients in Kharkiv, Ukraine Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016